Signet Management USA’s Pfizer PFE Stock Holding History

Signet Management USA’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$352K	Buy	+12,124	New	+$353K	0.24%	77

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Signet Management USA's PFE Position: Q4 2013 in Review

Signet Management USA opened a new position in Pfizer (PFE) in Q4 2013: 12,124 shares worth $352K. The stake represents 0.24% of the portfolio and ranks #77 among its holdings.

1,735 funds tracked by Wall St. Rank hold PFE as of Q4 2013.

Signet Management USA held 12,124 shares of Pfizer worth $352K as of Q4 2013.
Pfizer was a new Signet Management USA position in Q4 2013.
Pfizer made up 0.24% of Signet Management USA's portfolio in Q4 2013, its #77 holding.
1,735 funds tracked by Wall St. Rank held Pfizer as of Q4 2013.

Based on Signet Management USA's 13F filing for Q4 2013, filed 11 Feb 2014.